Evaluation of the Effects of Equicoaching on Social Reintegration Among Young Adults Who Have Bee… (NCT07515274) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluation of the Effects of Equicoaching on Social Reintegration Among Young Adults Who Have Been Treated for Cancer
France10 participantsStarted 2026-04-05
Plain-language summary
This is a category 2 human research study (RIPH), interventional, single-center, prospective, open-label.
The primary objective of this study is to qualitatively assess the effects of equicoaching on social reintegration in young adults who have been treated for cancer.
The secondary objectives are to evaluate the contribution of equicoaching to:
1. Self-confidence;
2. Well-being
3. Quality of life Satisfaction with equicoaching will also be evaluated.
Who can participate
Age range
15 Years – 25 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Have been treated for a malignant oncological or hematological condition.
* Be between 15 and 25 years of age at the time of cancer diagnosis. This age range corresponds to that chosen by the Leon Berard Cancer Center (CLB) and the Institute of Pediatric Hematology and Oncology (IHOPe) for the Adolescents and Young Adults with Cancer (DAJAC) program
* Have been treated at IHOPe/CLB as part of the DAJAC program
* Have completed intensive treatment within the last twelve months.
* Be able to understand, read, and write French
* Be affiliated with a health insurance plan
* Have been informed about the study and have given consent
For minors:
* All of the above criteria
* Parent/legal guardian informed about the study and having given consent
Exclusion Criteria:
* Patient deprived of liberty by judicial or administrative decision
* Pregnant or breastfeeding women
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.